Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Niagen Bioscience (NAGE) over the last 17 years, with Q3 2025 value amounting to $4.6 million.

  • Niagen Bioscience's Profit After Tax rose 14377.0% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.5 million, marking a year-over-year increase of 128154.88%. This contributed to the annual value of $8.6 million for FY2024, which is 27415.96% up from last year.
  • Niagen Bioscience's Profit After Tax amounted to $4.6 million in Q3 2025, which was up 14377.0% from $3.6 million recorded in Q2 2025.
  • Niagen Bioscience's 5-year Profit After Tax high stood at $7.2 million for Q4 2024, and its period low was -$8.9 million during Q3 2021.
  • For the 5-year period, Niagen Bioscience's Profit After Tax averaged around -$1.4 million, with its median value being -$985000.0 (2022).
  • In the last 5 years, Niagen Bioscience's Profit After Tax crashed by 11010.68% in 2021 and then surged by 2416000.0% in 2025.
  • Quarter analysis of 5 years shows Niagen Bioscience's Profit After Tax stood at -$5.3 million in 2021, then soared by 73.37% to -$1.4 million in 2022, then soared by 108.04% to $114000.0 in 2023, then surged by 6241.23% to $7.2 million in 2024, then plummeted by 36.67% to $4.6 million in 2025.
  • Its Profit After Tax was $4.6 million in Q3 2025, compared to $3.6 million in Q2 2025 and $5.1 million in Q1 2025.